SHB | bioCADDIE Data Discovery Index
Mountain View
biomedical and healthCAre Data Discovery Index Ecosystem
help Advanced Search
Displaying 5 of 5 results for "SHB"
  1. ShB peptide structure bound to negatively charged lipid-bilayer after Molecular Dynamics refinement PDB

    ID: PDB:2LNY

    Description: ShB peptide

  2. FGFR1_RAT UniProt:Swiss-Prot

    ID: Q04589

    Description: cal Cytoplasmic Ig-like C2-type 1 Ig-like C2-type 2 Ig-like C2-type 3 Protein kinase ATP ATP Heparin-binding Proton acceptor ATP ATP ATP ATP Mediates interaction with PLCG1 and SHB Phosphotyrosine;...

  3. Neutron Crystal Structure of Photoactive Yellow Protein, Wild type, at 295K PDB

    ID: PDB:2ZOI

    Description: Photoactive yellow protein

  4. VGFR2_RAT UniProt:Swiss-Prot

    ID: O08775

    Description: Vascular endothelial growth factor receptor 2 Extracellular Helical Cytoplasmic Ig-like C2-type 1 Ig-like C2-type 2 Ig-like C2-type 3 Ig-like C2-type 4 Ig-l...

  5. The anticancer effects of tanshinone I in human non-small-cell lung cancer BioProject

    ID: PRJNA102975

    Keywords: Transcriptome or Gene expression

    Access Type: download

    dataset.description: attenuating the DNA-binding activity of activator protein-1 and nuclear factor kappaB in CM-stimulated CL1-5 cells. Microarray and pathway analysis of tumor-related genes identified the differentially expressed genes responding to tanshinone I, and these results were validated by RTQ-PCR. The responsive genes included human platelet-derived growth factor beta chain, Shb, H-ras, N-Ras, mitogen-activated protein kinase kinase 3, phosphoinositide-3-kinase, CD44, Rac1, and collagen type IV; these genes may be associated with the Ras MAPK and Rac1 signaling pathways. These results suggest that tanshinone I exhibits anticancer effects both in vitro and in vivo, and that these effects are mediated at least partly through the IL-8, Ras MAPK, and Rac1 signaling pathways. Keywords: treatment with dose respone, cDNA array Overall design: Five concentrations of tanshinone I in CM were used: 0, 0.01, 0.1, 1, 10 ug/mL; in addition to a control condition without CM. Thirty micrograms of total RNA derived from CL1-5 cells from each treatment described above were labe...

Displaying 5 of 5 results for "SHB"